References
- Abalain-Colloc M.L., Guillerm D., Saläun M., Gouriou S., Vincent V., Picard B.: Mycobacterium szulgai isolated from a patient, a tropical fish and aquarium water. Eur J Clin Microbiol Infect Dis 2003, 22, 768–769, doi: 10.1007/s10096-003-1036-x.
- Adékambi T., Stein A., Carvajal J., Raoult D., Drancourt M.: Description of Mycobacterium conceptionense sp. nov., a Mycobacerium fortuitum group organism isolated from a posttraumatic osteitis inflammation. J Clin Microbiol 2006, 44, 1268–1273, doi: 10.1128/JCM.44.4.1268-1273.2006.
- Aubry A., Jarlier V., Escolano S., Truffot-Pernot C., Cambau E.: Antibiotic susceptibility pattern of Mycobacterium marinum. Antimicrob Agents Chemother 2000, 44, 3133–3136, doi: 10.1128 /aac.44.11.3133-3136.2000.
- Basnet S., Mir I., Dhital R., Basnet G., Patel N.: Mycobacterium mucogenicum hand infection in an intravenous drug abuser. Case Rep Infect Dis 2018, 1258649, 1–3, doi: 10.1155/2018/1258649.
- Bråbäck M., Riesbeck K., Forsgren A.: Susceptibilities of Mycobacterium marinum to gatifloxacin, gemifloxacin, levofloxacin, linezolid, moxifloxacin, telithromycin, and quinupristin-dalfopristin (Synercid) compared to its susceptibilities to reference macrolides and quinolones. Antimicrob Agents Chemother 2002, 46, 1114–1116, doi: 10.1128/aac.46.4.1114-1116.2002.
- Brown B.A., Wallace R.J.Jr., Onyi G.O., De Rosas V., Wallace R.J.III.: Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum Mycobacterium chelonae, and Mycobacterium chelonae-like organisms. Antimicrob Agents Chemother 1992, 36, 180–184, doi: 10.1128/aac.36.1.180.
- Brown-Elliott B.A., Crist C.J., Mann L.B., Wilson R.W., Wallace R.J.Jr.: In vitro activity of linezolid against slowly growing nontuberculous mycobacteria. Antimicrob Agents Chemother 2003, 47, 1736–1738, doi: 10.1128/aac.47.5.1736-1738.2003.
- Brown-Elliott B.A., Wallace R.J.Jr.: Clinical and taxonomic status of pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev 2002, 15, 716–746, doi: 10.1128/CMR.15.4.716-746.2002.
- Brown-Elliott B.A., Wallace R.J.Jr., Petti C.A., Mann L.B., McGlasson M., Chihara S., Smith G.L., Painter P., Hail D., Wilson R., Simmon K.E.: Mycobacterium neoaurum and Mycobacterium bacteremicum sp. nov. as causes of mycobacteremia. J Clin Microbiol 2010, 48, 4377–4385, doi: 10.1128/JCM.00853-10.
- Brown-Elliott B.A., Woods G.L.: Antimycobacterial susceptibility testing of nontuberculous mycobacteria. J Clin Microbiol 2019, 57, e00834-19, doi: 10.1128/JCM.00834-19.
- Chang C.T., Whipps C.M.: Activity of antibiotics against Mycobacterium species commonly found in laboratory zebrafish. J Aquat Anim Health 2015, 27, 88–95, doi: 10.1080/08997659.2015.1007176.
- Clinical and Laboratory Standards Institute: M24-A2 Susceptibility Testing of Mycobacteria, Nocardia, and other aerobic actinomycetes; Approved standard–Second Edition. CLSI, Wayne, 2011.
- Clinical and Laboratory Standards Institute: M100-S25 Performance Standards for Antimicrobial Susceptibility Testing; Twenty First Informational Supplement. CLSI, Wayne, 2015.
- Colombo R.E., Olivier K.N.: Diagnosis and treatment of infections caused by rapidly growing mycobacteria. Semin Respir Crit Care Med 2008, 29, 577–588, doi: 10.1055/s-0028-1085709.
- Decostere A., Hermans K., Haesebrouck F.: Piscine mycobacteriosis: a literature review covering the agent and the disease it causes in fish and humans. Vet Microbiol 2004, 99, 159–166, doi: 10.1016/j.vetmic.2003.07.011.
- Dibaj R., Shojaei H., Narimani T.: Identification and molecular characterization of mycobacteria isolated from animal sources in a developing country. Acta Trop 2020, 204, 105297, doi: 10.1016/j.actatropica.2019.105297.
- Gauthier D.T., Rhodes M.W.: Mycobacteriosis in fishes: A review. Vet J 2009, 180, 33–47, doi: 10.1016/j.tvjl.2008.05.012.
- Gcebe N., Michel A.L., Hlokwe T.M.: Non-tuberculous Mycobacterium species causing mycobacteriosis in farmed aquatic animals of South Africa. BMC Microbiol 2018, 18, 32, doi: 10.1186/s12866-018-1177-9.
- Giavenni R., Finazzi M., Poli G., Grimaldi E.: Tuberculosis in marine tropical fishes in an aquarium. J Wildl Dis 1980, 16, 161–168, doi: 10.7589/0090-3558-16.2.161.
- Go J.R., Wengenack N.L., Abu Saleh O.M., Corsini Campioli C., Deml S.M., Wilson J.W.: Mycobacterium septicum: a 6-year clinical experience from a Tertiary Hospital and Reference Laboratory. J Clin Microbiol 2020, 58, e02091-20, doi: 10.1128/JCM.02091-20.
- Goswami B., Narang P., Mishra P.S., Narang R., Narang U., Mendiratta D.K.: Drug susceptibility of rapid and slow growing non-tuberculous mycobacteria isolated from symptomatics for pulmonary tuberculosis, Central India. Indian J Med Microbiol 2016, 34, 442–447, doi: 10.4103/0255-0857.195375.
- Griffith D.E., Aksamit T., Brown-Elliott B.A., Catanzaro A., Daley C., Gordin F., Holland S.M., Horsburgh R., Huitt G., Iademarco M.F., Iseman M., Olivier K., Ruoss S., von Reyn C.F., Wallace R.J.Jr., Winthrop K.: An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007, 175, 367–416, doi: 10.1164/rccm.200604-571ST.
- Guz L., Grądzki Z., Krajewska M., Lipiec M., Zabost A., Augustynowicz-Kopeć E., Zwolska Z., Szulowski K.: Occurrence and antimicrobial susceptibility of Mycobacterium peregrinum in ornamental fish. Bull Vet Inst Pulawy 2013, 57, 489–492, doi: 10.2478/bvip-2013-0085.
- Han X.Y., Dé I., Jacobson K.L.: Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases. Am J Clin Pathol 2007, 128, 612–621, doi: 10.1309/1KB2GKYT1BUEYLB5.
- Hatakeyama S., Ohama Y., Okazaki M., Nukui Y., Moriya K.: Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan. BMC Infect Dis 2017, 17, 197, doi: 10.1186/s12879-017-2298-8.
- Hongslo T., Jansson E.: Occurrence of different species of mycobacteria in aquarium fish from Swedish pet-shops. Bull Eur Assoc Fish Pathol 2014, 34, 78–89.
- Huminer D., Pitlik S.D., Block C., Kaufman L., Amit S., Rosenfeld J.B.: Aquarium-borne Mycobacterium marinum skin infection. Arch Dermatol 1986, 122, 698–703.
- Jacobs J.M., Stine C.B., Baya A.M., Kent M.L.: A review of mycobacteriosis in marine fish. J Fish Dis 2009, 32, 119–130, doi: 10.1111/j.1365-2761.2008.01016.x.
- Kawakami K., Kusuda R.: Efficacy of rifampicin, streptomycin and erythromycin against experimental Mycobacterium infection in cultured yellowtail (in Japanese). Nippon Suisan Gakk 1990, 56, 51–53, doi: 10.2331/suisan.56.51.
- Kempisty A., Augustynowicz-Kopeć E., Opoka L., Szturmowicz M.: Mycobacterium szulgai lung disease or breast cancer relapse – case report. Antibiotics 2020, 9, 482, doi: 10.3390/antibiotics9080482.
- Kušar D., Zajc U., Jenčič V., Ocepek M., Higgins J., Žolnir-Dovč M., Pate M.: Mycobacteria in aquarium fish: results of a 3-year survey indicate caution required in handling pet-shop fish. J Fish Dis 2016, 40, 773–784, doi: 10.1111/jfd.12558.
- Kwiatkowska S., Augustynowicz-Kopeć E., Korzeniewska-Koseła M., Filipczak D., Gruszczyński P., Zabost A., Klatt M., Sadkowska-Todys M.: Nontuberculous mycobacteria strains isolated from patients between 2013 and 2017 in Poland. Our data with respect to the global trends. Adv Respir Med 2018, 86, 291–298, doi: 10.5603/ARM.a2018.0047.
- Lee S.M., Kim J.M., Jeong J., Park Y.K., Bai G.-H., Lee E.Y., Lee M.K., Chang C.L.: Evaluation of the broth microdilution method using 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride for rapidly growing mycobacteria susceptibility testing. J Korean Med Sci 2007, 22, 784–790, doi: 10.3346/jkms.2007.22.5.784.
- Lescenko P., Matlova L., Dvorska L., Bartos M., Vavra O., Navratil S., Novotny L., Pavlik I.: Mycobacterial infection in aquarium fish. Vet Med – Czech 2003, 48, 71–78, doi: 10.17221/5752-VETMED.
- Li G., Lian L.-L., Wan L., Zhang J., Zhao X., Jiang Y., Zhao L.-L., Liu H., Wan K.: Antimicrobial susceptibility of standard strains of nontuberculous mycobacteria by microplate alamar blue assay. PloS One 2013, 8, e84065, doi: 10.1371/journal.pone.0084065.
- Lian L.-L., Deng J., Zhao X., Dong H., Zhang J., Li G., Xiao T., Wu Y., Li Q., Wan K.: The first case of pulmonary disease caused by Mycobacterium septicum in China. Int. J Infect Dis 2013, 17, E352–E354, doi: 10.1016/j.ijid.2012.12.011.
- Martin A., Paasch F., Docx S., Fissette K., Imperiale B., Ribón W., González L.A., Werngren J., Engström A., Skenders G., Juréen P., Hoffner S., Del Portillo P., Morcillo N., Palomino J.C.: Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosis. J Antimicrob Chemother 2011, 66, 827–833, doi: 10.1093/jac/dkq527.
- Meir M., Barkan D.: Alternative and experimental therapies of Mycobacterium abscessus infections. Int J Mol Sci 2020, 21, 6793, doi: 10.3390/ijms21186793.
- Nash K.A., Brown-Elliott B.A., Wallace R.J.Jr.: A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob Agents Chemother 2009, 53, 1367–1376, doi: 10.1128/AAC.01275-08.
- Nogueira C.L., Whipps C.M., Matsumoto C.K., Chimara E., Droz S., Tortoli E., de Freitas D., Cnockaert M., Palomino J.C., Martin A., Vandamme P., Leão S.C.: Mycobacterium saopaulense sp. nov., a rapidly growing mycobacterium closely related to members of the Mycobacterium chelonae Mycobacterium abscessus group. Int J Syst Evol Microbiol 2015, 65, 4403–4409, doi: 10.1099/ijsem.0.000590.
- Novotny L., Dvorska L., Lorencova A., Beran V., Pavlik I.: Fish: a potential source of bacterial pathogens for human beings. Vet Med – Czech 2004, 49, 343–358, doi: 10.17221/5715-VETMED.
- Parte A.C., Sardà Carbasse J., Meier-Kolthoff J.P., Reimer L.C., Göker M.: List of Prokaryotic Names with Standing in Nomenclature (LPSN) moves to the DSMZ. Int J Syst Evolut Microbiol 2020, 70, 5607–5612, doi: 10.1099/ijsem.0.004332.
- Petrini B.: Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS 2006, 114, 319–328, doi: 10.1111/j.1600-0463.2006.apm_390.x.
- Puk K., Guz L.: Occurrence of Mycobacterium spp. in ornamental fish. Ann Agric Environ Med 2020, 27, 535–539, doi: 10.26444/aaem/114913.
- Puk K., Banach T., Wawrzyniak A., Adaszek Ł., Ziętek J., Winiarczyk S., Guz L.: Detection of Mycobacterium marinum M. peregrinum M. fortuitum and M. abscessus in aquarium fish. J Fish Dis 2018, 41, 153–156, doi: 10.1111/jfd.12666.
- Rakhmawatie M.D., Wibawa T., Lisdiyanti P., Pratiwi W.R., Mustofa: Evaluation of crystal violet decolorization assay and resazurin microplate assay for antimycobacterial screening. Helion 2019, 5, e02263, doi: 10.1016/j.heliyon.2019.e02263.
- Rhomberg P.R., Jones R.N.: In vitro activity of 11 antimicrobial agents, including gatifloxacin and GAR936, tested against clinical isolates of Mycobacterium marinum. Diagn Microbiol Infect Dis 2002, 42, 145–147, doi: 10.1016/s0732-8893(01)00332-7.
- Santos A., Cremades R., Rodriguez J.C., Ruiz M., Royo G., Garcia-Pachon E.: Mycobacterium peregrinum: bactericidal activity of antibiotics alone and in combination. J Infect Chemother 2008, 14, 262–263, doi: 10.1007/s10156-008-0611-6.
- Schinsky M.F., McNeil M.M., Whitney A.M., Steigerwalt A.G., Lasker B.A., Floyd M.M., Hogg G.G., Brenner D.J., Brown J.M.: Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. Int J Syst Evol Microbiol 2000, 50, 575–581, doi: 10.1099/00207713-50-2-575.
- Seyfahmadi M., Moaddab S.R., Sabokbar A.: Identification of mycobacteria from unhealthy and apparently healthy aquarium fish using both conventional and PCR analyses of hsp65 gene. Thai J Vet Med 2017, 47, 571–578.
- Shen Y., Wang X., Jin J., Wu J., Zhang X., Chen J., Zhang W.: In vitro susceptibility of Mycobacterium abscessus and Mycobacterium fortuitum isolates to 30 antibiotics. BioMed Res Int 2018, 4902941, 1–10, doi: 10.1155/2018/4902941.
- Springer B., Böttger E.C., Kirschner P., Wallace R.J.Jr.: Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. Int J Syst Bacteriol 1995, 45, 262–267, doi: 10.1099/00207713-45-2-262.
- Swenson J.M., Wallace R.J.Jr., Silcox V.A., Thornsberry C.: Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae. Antimicrob Agents Chemother 1985, 28, 807–811, doi: 10.1128/aac.28.6.807.
- Talavlikar R., Carson J., Meatherill B., Desai S., Sharma M., Shandro C., Tyrrell G.J., Kuhn S.: Mycobacterium senegalense tissue infection in a child after fish tank exposure. Can J Infect Dis Med Microbiol 2011, 22, 101–103, doi: 10.1155/2011/206532.
- Tortoli E., Besozzi G., Lacchini C., Penati V., Simonetti M.T., Emler S.: Pulmonary infection due to Mycobacterium szulgai: case report and review of the literature. Eur Respir J 1998, 11, 975–977, doi: 10.1183/09031936.98.11040975.
- Tsankova G., Kaludova V., Todorova T., Ermenlieva N., Georgieva E.: Nontuberculous tuberculosis caused by Mycobacterium gordonae – clinical case report. J IMAB 2015, 21, 856–858, doi: 10.5272/jimab.2015213.856.
- Van Ingen J., Griffith D.E., Aksamit T.R., Wagner D.: Pulmonary diseases caused by non-tuberculous mycobacteria. Eur Respir Monogr 2012, 58, 25–37, doi: 10.1183/1025448x.10022511.
- Van Ingen J., van der Laan T., Dekhuijzen R., Boeree M., van Soolingen D.: In vitro drug susceptibility of 2275 clinical non-tuberculous Mycobacterium isolates of 49 species in the Netherlands. Int J Antimicrob Agents 2010, 35, 169–173, doi: 10.1016/j.ijantimicag.2009.09.023.
- Van Ingen J., Boeree M.J., de Lange W.C.M., de Haas P.E.W., Dekhuijzen P.N.R., van Soolingen D.: Clinical relevance of Mycobacterium szulgai in The Netherlands. Clin Infect Dis 2008, 46, 1200–1205, doi: 10.1086/529443.
- Vera-Cabrera L., Brown-Elliott B.A., Wallace R.J.Jr., Ocampo-Candiani J., Welsh O., Choi S.H., Molina-Torres C.A.: In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria. Antimicrob Agents Chemother 2006, 50, 4027–4029, doi: 10.1128/AAC.00763-06.
- Wallace R.J.Jr., Brown B.A., Onyi G.: Susceptibilities of M. fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid. Antimicrob Agents Chemother 1991, 35, 773–775, doi: 10.1128/aac.35.4.773.
- Wallace R.J.Jr., Brown-Elliot B.A., Brown J., Steigerwalt A.G., Hall L., Woods G., Cloud J., Mann L., Wilson R., Crist C., Jost K.C.Jr., Byrer D.E., Tang J., Cooper J., Stamenova E., Campbell B., Wolfe J., Turenne C.: Polyphasic characterization reveals that the human pathogen Mycobacterium peregrinum type II belongs to the bovine pathogen species Mycobacterium senegalense. J Clin Microbiol 2005, 43, 5925–5935, doi: 10.1128/JCM.43.12.5925-5935.2005.
- Watral V., Kent M.L.: Pathogenesis of Mycobacterium spp. in zebrafish (Danio rerio) from research facilities. Comp Biochem Physiol C 2007, 145, 55–60, doi: 10.1016/j.cbpc.2006.06.004.
- Whipps C.M., Lieggi C., Wagner R.: Mycobacteriosis in zebrafish colonies. ILAR Journal 2012, 53, 95–105, doi: 10.1093/ilar.53.2.95.
- World Health Organization: Joint FAO/OIE/WHO Expert workshop on non-human antimicrobial usage and antimicrobial resistance: scientific assessment. WHO, Geneva, 2004. https://apps.who.int/iris/handle/10665/68883
- World Health Organization: Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. WHO, Geneva, 2008. https://www.who.int/tb/publications/2008/whohtmtb_2008_392/en
- Yakrus M.A., Hernandez S.M., Floyd M.M., Sikes D., Butler W.R., Metchock B.: Comparison of methods for identification of Mycobacterium abscessus and M. chelonae isolates. J Clin Microbiol 2001, 39, 4103–4110, doi: 10.1128/JCM.39.11.4103-4110.2001.